---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-24-002731"
form_type: "8-K"
ticker: "OM"
cik: "0001484612"
company_name: "Outset Medical, Inc."
filed_at: "2024-01-08T23:59:59+00:00"
generated_at: "2026-06-07T02:12:22.368497+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Outset Medical reports Q4 rev $30.5M, FY2023 $130M (+13%), guides 2024 rev $145-153M

## Summary
- Q4 revenue $30.5M; FY2023 revenue $130M, up 13% YoY.
- Installed base up 34% YoY to ~5,350 Tablo systems; consumable revenue grew nearly 50% YoY.
- Recurring revenue exceeded 50% of total revenue in 2023.
- Borrowed $66.5M in Jan 2024; cash position ~$270M.
- 2024 guidance: revenue $145-153M (12-18% growth); non-GAAP gross margin low-30% for year, mid-30% in Q4.

## SEC filing metadata
- accession: 0000950170-24-002731
- form_type: 8-K
- ticker: OM
- cik: 0001484612
- company_name: Outset Medical, Inc.
- filed_at: 2024-01-08T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1484612/000095017024002731/0000950170-24-002731-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1484612/000095017024002731/om-20240108.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-24-002731
- JSON: https://secwatch.observer/filing/0000950170-24-002731.json
- Plain text: https://secwatch.observer/filing/0000950170-24-002731.txt

## Key facts
- Earnings Releases
  Outset Medical, Inc. reported the fourth quarter and fiscal year ended December 31, 2023 results: revenue $30.5 million. Guidance initiated.
  - Period: the fourth quarter and fiscal year ended December 31, 2023
  - Revenue: $30.5 million
  - Guidance: initiated
  - Result: preliminary results
  source text: year ended December 31, 2023, and provided 2024 financial guidance. Unaudited Fourth Quarter and Year End Results, and Recent Highlights • Revenue in the fourth quarter totaled $30.5 million, bringing revenue for 2023 to $130 million, a 13% increase compared to $115 million in 2022. • Period-end installed base increased 34% year-over-year to approximately 5,350
  evidence_url: https://www.sec.gov/Archives/edgar/data/1484612/000095017024002731/0000950170-24-002731-index.htm
- Earnings Releases
  Outset Medical, Inc. reported the full year 2024 results: revenue between $145 million to $153 million. Guidance initiated.
  - Period: the full year 2024
  - Revenue: between $145 million to $153 million
  - Guidance: initiated
  - Result: guidance update
  source text: Outset expects 2024 revenue to be between $145 million to $153 million
  evidence_url: https://www.sec.gov/Archives/edgar/data/1484612/000095017024002731/0000950170-24-002731-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.